Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment

NCT00421889

Conditions
Adnexal Diseases, Bladder Cancer, Carcinoma, +27 more
Locations
  • Gynecologic Oncology Associates Newport Beach, California, United States
  • Research Facility Orlando, Florida, United States
  • Hematology and Oncology Specialists, LLC Covington, Louisiana, United States
  • Hematology & Oncology Specialists, LLC Metairie, Louisiana, United States
View Trial Details
Completed

Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter

NCT00066352

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • Decatur Memorial Hospital Cancer Care Institute Decatur, Illinois, United States
  • CCOP - Evanston Evanston, Illinois, United States
  • Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey, Illinois, United States
View all 15 locations
View Trial Details
Completed

Tipifarnib in Treating Patients With Recurrent Bladder Cancer

NCT00047216

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • University of Chicago Cancer Research Center Chicago, Illinois, United States
  • Louis A. Weiss Memorial Hospital Chicago, Illinois, United States
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • St. Joseph's Hospital Hamilton, Ontario, Canada
View Trial Details
Completed

ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma

NCT00420888

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Department of Chemotherapy, University General Hospital for Active Treatment "Georgi Stranski" Pleven, Bulgaria
  • 1st Internal Department District Dispensary for Cancer Diseases with Inpatient Hospital Plovdiv, Bulgaria
  • Multifile Hospital "Aleksandrovska", Urology Clinic, Department of Oncourology Sofia, Bulgaria
  • Oncology Clinic, University General Hospital for Active Treatment "Tzaritza Yoanna" Sofia, Bulgaria
View all 51 locations
View Trial Details
Completed

Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma

NCT00413075

Conditions
Adenoma, Adenosarcoma, Adnexal Diseases, +89 more
Locations
  • Yale New Haven Hospital New Haven, Connecticut, United States
  • Columbia University - Herbert Irving Cancer Center New York, United States
  • New York University Cancer Institute New York, United States
  • M.D. Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions